The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

BOSTON—Clinicians may want to rethink the antibiotics they prescribe for vancomycin-resistant Enterococcus (VRE) urinary tract infections (UTIs). A new retrospective study presented at the 50 th ...

The U.S. Food and Drug Administration has granted approval to a new antibiotic to treat urinary tract infections in women and adolescent girls. The drug is made by British pharmaceutical company GSK.

The incidence of enterococcal infections has been increasing over the past few years, with rising rates of multidrug resistance. VRE is increasingly a problem in many hospitals and intensive care ...

Cystitis and urinary tract infections can be a recurrent problem for many people. The pathogenic bacteria that can cause these bladder infections are also becoming increasingly resistant to ...